Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 16;11(24):4075.
doi: 10.3390/cells11244075.

Recent Advances in the Study of Na+/K+-ATPase in Neurodegenerative Diseases

Affiliations
Review

Recent Advances in the Study of Na+/K+-ATPase in Neurodegenerative Diseases

Xiaoyan Zhang et al. Cells. .

Abstract

Na+/K+-ATPase (NKA), a large transmembrane protein, is expressed in the plasma membrane of most eukaryotic cells. It maintains resting membrane potential, cell volume and secondary transcellular transport of other ions and neurotransmitters. NKA consumes about half of the ATP molecules in the brain, which makes NKA highly sensitive to energy deficiency. Neurodegenerative diseases (NDDs) are a group of diseases characterized by chronic, progressive and irreversible neuronal loss in specific brain areas. The pathogenesis of NDDs is sophisticated, involving protein misfolding and aggregation, mitochondrial dysfunction and oxidative stress. The protective effect of NKA against NDDs has been emerging gradually in the past few decades. Hence, understanding the role of NKA in NDDs is critical for elucidating the underlying pathophysiology of NDDs and identifying new therapeutic targets. The present review focuses on the recent progress involving different aspects of NKA in cellular homeostasis to present in-depth understanding of this unique protein. Moreover, the essential roles of NKA in NDDs are discussed to provide a platform and bright future for the improvement of clinical research in NDDs.

Keywords: Na+/K+-ATPase; mitochondrial dysfunction; neurodegenerative diseases; oxidative stress; protein–protein interaction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of NKA structure. NKA contains the α, β and γ subunits. The extracellular region897 DVEDSYGQQWTYEQR911 (DR region) of the α subunit is associated with the β subunit. The hexagons (yellow and red) depicted above are two binding sites for α-synuclein fibrils and spherical amyloid β (Aβ) oligomers that are close to the DR region [25,26].
Figure 2
Figure 2
Schematic illustration showing how ASPD secretion from the excitatory neurons induces neuronal loss and vascular pathologies. In response to central nervous system (CNS) damage, astrocytic NKAα2 level was upregulated and contributed to astrogliosis [59]. The activated astrocytes then secreted more proinflammatory protein lipocalin-2 (Lcn-2) to neurons, causing neurons to uptake more extracellular tau and resulting in the formation of the neurofibrillary tangles [59].
Figure 3
Figure 3
Interactions between α-syn and NKA α subunit in the extracellular and intracellular segments. Left panel: α-syn bound to the neuronal membrane and formed a complex with NKAα3. This complex impaired NKAα3 activity and increased glutamate-induced Ca2+ influx to induce neuronal loss. Right panel: Intracellular part of NKAα1 formed a complex with α-syn/AMPKα to translocate AMPKα to the plasma membrane. DR5-12D prevented the formation of this complex and alleviated the symptoms of PD.

Similar articles

Cited by

References

    1. Sierra-Fonseca J.A., Gosselink K.L. Tauopathy and neurodegeneration: A role for stress. Neurobiol. Stress. 2018;9:105–112. doi: 10.1016/j.ynstr.2018.08.009. - DOI - PMC - PubMed
    1. Kumar R., Amruthanjali T., Singothu S., Singh S.B., Bhandari V. Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder. Biomed. Pharmacother.=Biomed. Pharmacother. 2022;147:112656. doi: 10.1016/j.biopha.2022.112656. - DOI - PubMed
    1. Ruffini N., Klingenberg S., Schweiger S., Gerber S. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. Cells. 2020;9:2642. doi: 10.3390/cells9122642. - DOI - PMC - PubMed
    1. Marques-Aleixo I., Beleza J., Sampaio A., Stevanović J., Coxito P., Gonçalves I., Ascensão A., Magalhães J. Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases. Antioxid. Redox Signal. 2021;34:674–693. doi: 10.1089/ars.2020.8075. - DOI - PubMed
    1. Teixeira F.C., Gutierres J.M., Soares M.S.P., da Siveira de Mattos B., Spohr L., do Couto C.A.T., Bona N.P., Assmann C.E., Morsch V.M., da Cruz I.B.M., et al. Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: A nucleoside with multitarget brain actions. Psychopharmacology. 2020;237:811–823. doi: 10.1007/s00213-019-05419-5. - DOI - PubMed

Publication types